MedPath

Mechanisms of Infertility and Hormonal Changes in Patients With Chronic Kidney Disease

Withdrawn
Conditions
Infertility
Registration Number
NCT01294904
Lead Sponsor
Lund University
Brief Summary

Patients with chronic kidney disease (both men and women), especially those with terminal renal failure, manifest infertility. There has been demonstrated several hormonal changes in patients on dialysis. Increased levels of luteinizing hormone (LH) has been seen in men (12). In women the opposite has been reported. The number of spermatocytes is reduced and a disturbance in maturation has been observed.

This project is aimed to study the influence of uremic milieu on fertility in men and women. The hypopituitary/hypothalamus gland axis and hormonal levels will be studied.

Detailed Description

Renal elimination of hormones and peptides. By using a human transplantation model the investigators will study changes in hormonal levels before and after a successful transplantation up to 12 months. Hormones: testosterone, SHBG (sex hormone binding globulin), LH (luteinizing hormone), FSH (follicle stimulating hormone), estradiol and inhibin B.

Analysis of sperm quality, concentration, motility, morphology and as well DNA-fragmentation index (DFI) in men with chronic kidney disease. In women the investigators will study the maturation of follicles via vaginal ultrasound. Controls are persons from a study at Dept of Reproductive Medicine.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • GFR-levels
Exclusion Criteria
  • > 50 years old

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
concentration of sex hormone levels in plasmaup to three years
Secondary Outcome Measures
NameTimeMethod
sperm motilityup to three years

Trial Locations

Locations (2)

Dag Eckersten

🇸🇪

Malmö, Sweden

SUS, Malmö, Sweden

🇸🇪

Malmö, Sweden

© Copyright 2025. All Rights Reserved by MedPath